Authors
Loading...
Provides no basis for altering clinical lipid therapies; leaves open Hep3B and NPLC cells for modeling hepatic lipoprotein production.
Key points are not available for this paper at this time.
Forte et al. (1989) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: